The UK national external quality assessment scheme for heritable bleeding disorders

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 2, 2014, Pages 261-268

  Perry, David J ^a   Cumming, Tony ^b   Goodeve, Anne ^c   Hill, Marian ^d   Jennings, Ian ^e   Kitchen, Steven ^f   Walker, Isobel ^e  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e UK NEQAS for Blood Coagulation   (United Kingdom)

^f ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

hemophilia; molecular genetics; mutational analysis; quality assurance

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DNA; VON WILLEBRAND FACTOR;

ACCREDITATION; ARTICLE; BLEEDING DISORDER; BLOOD; BLOOD CLOTTING; DNA ISOLATION; DNA SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE; HEMOPHILIA A; HEMOPHILIA B; HUMAN; LABORATORY; MISSENSE MUTATION; MOLECULAR GENETICS; PRIORITY JOURNAL; QUALITY CONTROL; SCORING SYSTEM; UNITED KINGDOM; VON WILLEBRAND DISEASE; WORKLOAD; CELL LINE; DIAGNOSTIC PROCEDURE; GENETICS; HEMORRHAGIC DISORDERS; NUCLEOTIDE SEQUENCE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; TOTAL QUALITY MANAGEMENT; TRENDS;

CELL LINE; CLINICAL LABORATORY TECHNIQUES; DNA MUTATIONAL ANALYSIS; FACTOR IX; FACTOR VIII; GENETIC TESTING; GENOTYPE; GREAT BRITAIN; HEMORRHAGIC DISORDERS; HUMANS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOTAL QUALITY MANAGEMENT; VON WILLEBRAND FACTOR;

EID: 84896714153     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1365843     Document Type: Article

References (21)

1. Schwarz J., Astermark J., Menius E. D., et al. Hemophilia Inhibitor Genetics Study Combined Cohort. F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Haemophilia: 2013; 19 1 113 118
2. Gouw S. C., van den Berg H. M., Oldenburg J., et al. F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood: 2012; 119 12 2922 2934
3. Tripodi A., Peyvandi F., Chantarangkul V., Menegatti M., Mannucci P. M. Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations-A cause for concern. Thromb Haemost: 2002; 88 4 690 691
4. Preston F. E., Kitchen S., Jennings I., Woods T. A. A UK National External Quality Assessment scheme (UK Neqas) for molecular genetic testing for the diagnosis of familial thrombophilia. Thromb Haemost: 1999; 82 5 1556 1557
5. Mueller C. R., Kristoffersson U., Stoppa-Lyonnet D. External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years. Ann Oncol: 2004; 15 01 I14 I17
6. Hertzberg M., Neville S., Favaloro E., McDonald D. External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol: 2005; 123 2 189 193
7. Dequeker E., Cassiman J. J. Genetic testing and quality control in diagnostic laboratories. Nat Genet: 2000; 25 3 259 260
8. EQA Schemes. http://www.emqn.org/emqn/Schemes. Accessed January 30, 2014
9. Keeney S., Mitchell M., Goodeve A.; UK Haemophilia Center Doctors' Organization Haemophilia Genetics Laboratory Network. The molecular analysis of haemophilia A: a guideline from the UK haemophilia centre doctors' organization haemophilia genetics laboratory network. Haemophilia: 2005; 11 4 387 397
10. Keeney S., Bowen D., Cumming A., Enayat S., Goodeve A., Hill M.; UK Haemophilia Centre Doctors' Organisation (UKHCDO). The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network. Haemophilia: 2008; 14 5 1099 1111
11. Mitchell M., Keeney S., Goodeve A.; UK Haemophilia Centre Doctors' Organization Haemophilia Genetics Laboratory Network. The molecular analysis of haemophilia B: a guideline from the UK haemophilia centre doctors' organization haemophilia genetics laboratory network. Haemophilia: 2005; 11 4 398 404
12. Kernoff P. B., Lee C. A., Karayiannis P., Thomas H. C. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol: 1985; 60 3 469 479
13. Darby S. C., Ewart D. W., Giangrande P. L., Dolin P. J., Spooner R. J., Rizza C. R. Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation. Nature: 1995; 377 6544 79 82
14. Perry D. J., Goodeve A., Hill M., Jennings I., Kitchen S., Walker I.; UK NEQAS for Blood Coagulation. The UK National External Quality Assessment Scheme (UK NEQAS) for molecular genetic testing in haemophilia. Thromb Haemost: 2006; 96 5 597 601
15. Antonarakis S. E., Rossiter J. P., Young M., et al. Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood: 1995; 86 6 2206 2212
16. Liu Q., Nozari G., Sommer S. S. Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A. Blood: 1998; 92 4 1458 1459
17. Rossetti L. C., Radic C. P., Larripa I. B., De Brasi C. D. Genotyping the hemophilia inversion hotspot by use of inverse PCR. Clin Chem: 2005; 51 7 1154 1158
18. Bagnall R. D., Waseem N., Green P. M., Giannelli F. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood: 2002; 99 1 168 174
19. Best Practice Guidelines. http://www.cmgs.org/BPGs/Best-Practice- Guidelines.htm. Accessed January 30, 2014
20. Ludlam C. A., Pasi K. J., Bolton-Maggs P., et al. UK Haemophilia Centre Doctors' Organisation. A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia: 2005; 11 2 145 163
21. den Dunnen J. Nomenclature for the description of sequence variants. Human Genome Variation Society Web site. http://www.hgvs.org/mutnomen/. Accessed January 30, 2014